Capture

PRODUCTS

  • From product development to translation into clinical trials, GTx’s clinically validated scalable electroporation technology is equipped to handle your most complex cellular engineering demands.

    • Rapidly transfect from 75 thousand to 20 billion cells
    • Move forward with 21 CFR Part 11 enabled software
    • Develop quickly with an established regulatory path supported by a FDA Master File
    • Manufacture confidently with closed, cGMP-compliant, ISO-certified and CE-marked products
    • Enjoy MaxCyte’s proprietary Flow Electroporation® technology
  • Explore how an advanced Cell Line Development (CLD) platform for new biologics can enable CHO-based cell line development; ensure premium, stable, and high-yield results; overcome common expression bottlenecks; and provide robust verification, genomic characterization, and monoclonality assessment services.

  • LipidBrick® IM21.7c

    •  Efficient: Modulates LNP properties to adapt the biodistribution depending on the therapeutic purpose
    •  Secure: Use a unique lipid structure protected by an independent patent owned by Polyplus®
    •  Accelerate your project: in vitro and in vivo proof of concept have been successfully performed
  • Optical filters enhance system precision by selectively transmitting or blocking wavelengths, supporting machine vision, spectroscopy, fluorescence microscopy, and medical imaging with customizable solutions.

  • The CliniMACS Prodigy® represents the next generation in automated cell processing. This device offers advanced integrated solutions to streamline cell processing workflows – from cell separation through cell culture to formulation of the final product.

WHITE PAPERS AND CASE STUDIES

NEWS